Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

PrEP news

Show

From To
Dr Joseph Sonnabend: The WHO's unwise recommendation for gay men

Since we really have relatively very little information about PrEP, and almost none about its use on a population level such a broad recommendation by the WHO is absolutely inappropriate, so maybe faced with increasing HIV infections among gay men, the WHO is simply giving up and proposing an unproved intervention out of desperation.

Published
23 hours ago
From
POZ
Good adherence seen in study of intermittent PrEP

The first results published from the IPERGAY study, a trial of pre-exposure prophylaxis (PrEP) in gay men taking place in France and Quebec, Canada, appear to indicate

Published
22 July 2014
By
Gus Cairns
Overall PrEP effectiveness in iPrEx OLE study 50%, but 100% in those taking four or more doses a week

The open-label extension of the iPrEx study of pre-exposure prophylaxis (iPrEx OLE) reported its main findings at the 20th International AIDS Conference (AIDS 2014) in Melbourne, Australia

Published
22 July 2014
By
Gus Cairns
HIV, HCV and TB Pipeline Report

Drugs, diagnostics, vaccines, preventive technologies, research towards a cure, and immune-based and gene therapies in development.

Published
21 July 2014
From
Treatment Action Group & i-Base
Declining investment could slow research and rollout of new HIV prevention options

Investment in HIV prevention research fell US$50 million, or 4 percent, to US$1.26 billion in 2013, due to declining investments by the United States and European government donors, changes in the international development landscape and changes in the pipeline of HIV prevention products in various stages of development and implementation, according to a new report from the HIV Vaccines and Microbicides Resource Tracking Working Group.

Published
20 July 2014
From
HIV Vaccines and Microbicides Resource Tracking Working Group press release
HIV Prevention in Clinical Care Settings - 2014 Recommendations of the International Antiviral Society–USA Panel

In an innovative approach to HIV prevention, an interdisciplinary group of experts has come together for the first time to lay out a framework of best practices to optimize the role of the clinician in achieving an AIDS-free generation.

Published
19 July 2014
From
Journal of the American Medical Association
New Momentum on PrEP, But Critical Needs Are Overlooked

Oral PrEP should be integrated into comprehensive, high-impact prevention programs for all people at risk internationally, with particular attention to key populations but also for young women and married women who continue to bear the brunt of the epidemic. WHO needs to quickly issue guidance on PrEP for all of the populations that can benefit.

Published
19 July 2014
From
Huffington Post
European CDC cautious about PrEP

The European Centre for Disease Prevention and Control (ECDC) has issued a paper saying that it cannot make a clear Europe-wide recommendation on the use of pre-exposure prophylaxis

Published
18 July 2014
By
Gus Cairns
Is Truvada, the Pill to Prevent H.I.V., 99 Percent Effective? Don’t Be So Sure

All of the H.I.V. researchers and experts I spoke with for this article agree that Truvada works well to prevent H.I.V. infection and that its effectiveness is closely tied to frequency of dosing. But they did not all agree about how much to rely on the 99 percent estimate.

Published
17 July 2014
From
New York Times
WHO: No, Not All Gay Men Need to Take Antiretroviral Drugs

A new recommendation from the World Health Organization about who should take drugs to prevent HIV is causing confusion and controversy nationwide.

Published
17 July 2014
From
Healthline
← First12345...39Next →

Filter by country